- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Metabotropic Glutamate Receptor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Metabotropic Glutamate Receptor 2 market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Anxiety Disorders accounting for % of the Metabotropic Glutamate Receptor 2 global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While LY-2607540 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metabotropic Glutamate Receptor 2 include Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, and Eli Lilly and Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metabotropic Glutamate Receptor 2 market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Market segment by Application can be divided into
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
The key market players for global Metabotropic Glutamate Receptor 2 market are listed below:
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor 2, with price, sales, revenue and global market share of Metabotropic Glutamate Receptor 2 from 2019 to 2022.
Chapter 3, the Metabotropic Glutamate Receptor 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metabotropic Glutamate Receptor 2 market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabotropic Glutamate Receptor 2.
Chapter 13, 14, and 15, to describe Metabotropic Glutamate Receptor 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Metabotropic Glutamate Receptor 2 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor 2 Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 LY-2607540
1.2.3 BMT-133218
1.2.4 DT-2442
1.2.5 JNJ-40411813
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor 2 Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anxiety Disorders
1.3.3 Depression
1.3.4 Schizophrenia
1.3.5 Chronic Pain
1.3.6 Others
1.4 Global Metabotropic Glutamate Receptor 2 Market Size & Forecast
1.4.1 Global Metabotropic Glutamate Receptor 2 Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metabotropic Glutamate Receptor 2 Sales in Volume (2017-2028)
1.4.3 Global Metabotropic Glutamate Receptor 2 Price (2017-2028)
1.5 Global Metabotropic Glutamate Receptor 2 Production Capacity Analysis
1.5.1 Global Metabotropic Glutamate Receptor 2 Total Production Capacity (2017-2028)
1.5.2 Global Metabotropic Glutamate Receptor 2 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metabotropic Glutamate Receptor 2 Market Drivers
1.6.2 Metabotropic Glutamate Receptor 2 Market Restraints
1.6.3 Metabotropic Glutamate Receptor 2 Trends Analysis
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business
2.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product and Services
2.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product and Services
2.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Denovo Biopharma LLC
2.3.1 Denovo Biopharma LLC Details
2.3.2 Denovo Biopharma LLC Major Business
2.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product and Services
2.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Domain Therapeutics SA
2.4.1 Domain Therapeutics SA Details
2.4.2 Domain Therapeutics SA Major Business
2.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product and Services
2.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product and Services
2.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product and Services
2.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck & Co Inc
2.7.1 Merck & Co Inc Details
2.7.2 Merck & Co Inc Major Business
2.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product and Services
2.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metabotropic Glutamate Receptor 2 Breakdown Data by Manufacturer
3.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metabotropic Glutamate Receptor 2
3.4 Market Concentration Rate
3.4.1 Top 3 Metabotropic Glutamate Receptor 2 Manufacturer Market Share in 2021
3.4.2 Top 6 Metabotropic Glutamate Receptor 2 Manufacturer Market Share in 2021
3.5 Global Metabotropic Glutamate Receptor 2 Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metabotropic Glutamate Receptor 2 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metabotropic Glutamate Receptor 2 Market Size by Region
4.1.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2017-2028)
4.1.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2028)
4.2 North America Metabotropic Glutamate Receptor 2 Revenue (2017-2028)
4.3 Europe Metabotropic Glutamate Receptor 2 Revenue (2017-2028)
4.4 Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue (2017-2028)
4.5 South America Metabotropic Glutamate Receptor 2 Revenue (2017-2028)
4.6 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Type (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 2 Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Application (2017-2028)
6.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
6.3 Global Metabotropic Glutamate Receptor 2 Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
7.2 North America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
7.3 North America Metabotropic Glutamate Receptor 2 Market Size by Country
7.3.1 North America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028)
7.3.2 North America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
8.2 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
8.3 Europe Metabotropic Glutamate Receptor 2 Market Size by Country
8.3.1 Europe Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028)
8.3.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
9.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
9.3 Asia-Pacific Metabotropic Glutamate Receptor 2 Market Size by Region
9.3.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
10.2 South America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
10.3 South America Metabotropic Glutamate Receptor 2 Market Size by Country
10.3.1 South America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028)
10.3.2 South America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
11.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
11.3 Middle East & Africa Metabotropic Glutamate Receptor 2 Market Size by Country
11.3.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metabotropic Glutamate Receptor 2 and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metabotropic Glutamate Receptor 2
12.3 Metabotropic Glutamate Receptor 2 Production Process
12.4 Metabotropic Glutamate Receptor 2 Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metabotropic Glutamate Receptor 2 Typical Distributors
13.3 Metabotropic Glutamate Receptor 2 Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Metabotropic Glutamate Receptor 2 Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Metabotropic Glutamate Receptor 2 Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Addex Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Addex Therapeutics Ltd Major Business
Table 5. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product and Services
Table 6. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product and Services
Table 10. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Denovo Biopharma LLC Basic Information, Manufacturing Base and Competitors
Table 12. Denovo Biopharma LLC Major Business
Table 13. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product and Services
Table 14. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Domain Therapeutics SA Basic Information, Manufacturing Base and Competitors
Table 16. Domain Therapeutics SA Major Business
Table 17. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product and Services
Table 18. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product and Services
Table 22. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product and Services
Table 26. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co Inc Major Business
Table 29. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product and Services
Table 30. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Metabotropic Glutamate Receptor 2 Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Metabotropic Glutamate Receptor 2, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Metabotropic Glutamate Receptor 2 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 35. Head Office and Metabotropic Glutamate Receptor 2 Production Site of Key Manufacturer
Table 36. Metabotropic Glutamate Receptor 2 New Entrant and Capacity Expansion Plans
Table 37. Metabotropic Glutamate Receptor 2 Mergers & Acquisitions in the Past Five Years
Table 38. Global Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)
Table 39. Global Metabotropic Glutamate Receptor 2 Sales by Region (2023-2028) & (K Pcs)
Table 40. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 43. Global Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 44. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Metabotropic Glutamate Receptor 2 Price by Type (2017-2022) & (USD/Pcs)
Table 47. Global Metabotropic Glutamate Receptor 2 Price by Type (2023-2028) & (USD/Pcs)
Table 48. Global Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 49. Global Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 50. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Metabotropic Glutamate Receptor 2 Price by Application (2017-2022) & (USD/Pcs)
Table 53. Global Metabotropic Glutamate Receptor 2 Price by Application (2023-2028) & (USD/Pcs)
Table 54. North America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 55. North America Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 56. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 59. North America Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 60. North America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 61. North America Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 62. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 63. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 64. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 67. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 68. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 70. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)
Table 71. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2023-2028) & (K Pcs)
Table 72. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 75. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 76. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 78. South America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 79. South America Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 80. South America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 83. South America Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 84. South America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 85. South America Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)
Table 87. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Region (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 91. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 92. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 93. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 94. Metabotropic Glutamate Receptor 2 Raw Material
Table 95. Key Manufacturers of Metabotropic Glutamate Receptor 2 Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Metabotropic Glutamate Receptor 2 Typical Distributors
Table 99. Metabotropic Glutamate Receptor 2 Typical Customers
List of Figures
Figure 1. Metabotropic Glutamate Receptor 2 Picture
Figure 2. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type in 2021
Figure 3. LY-2607540
Figure 4. BMT-133218
Figure 5. DT-2442
Figure 6. JNJ-40411813
Figure 7. Others
Figure 8. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application in 2021
Figure 9. Anxiety Disorders
Figure 10. Depression
Figure 11. Schizophrenia
Figure 12. Chronic Pain
Figure 13. Others
Figure 14. Global Metabotropic Glutamate Receptor 2 Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 15. Global Metabotropic Glutamate Receptor 2 Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Metabotropic Glutamate Receptor 2 Sales (2017-2028) & (K Pcs)
Figure 17. Global Metabotropic Glutamate Receptor 2 Price (2017-2028) & (USD/Pcs)
Figure 18. Global Metabotropic Glutamate Receptor 2 Production Capacity (2017-2028) & (K Pcs)
Figure 19. Global Metabotropic Glutamate Receptor 2 Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Metabotropic Glutamate Receptor 2 Market Drivers
Figure 21. Metabotropic Glutamate Receptor 2 Market Restraints
Figure 22. Metabotropic Glutamate Receptor 2 Market Trends
Figure 23. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturer in 2021
Figure 24. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturer in 2021
Figure 25. Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Metabotropic Glutamate Receptor 2 Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Metabotropic Glutamate Receptor 2 Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2028)
Figure 29. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2017-2028)
Figure 30. North America Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (USD Million)
Figure 31. Europe Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (USD Million)
Figure 33. South America Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (USD Million)
Figure 35. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 36. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 37. Global Metabotropic Glutamate Receptor 2 Price by Type (2017-2028) & (USD/Pcs)
Figure 38. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 39. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 40. Global Metabotropic Glutamate Receptor 2 Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 42. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 43. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2028)
Figure 44. North America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2028)
Figure 45. United States Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 49. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 50. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2028)
Figure 51. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2028)
Figure 52. Germany Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2017-2028)
Figure 61. China Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 68. South America Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 69. South America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2017-2028)
Figure 70. South America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 2 in 2021
Figure 82. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2
Figure 83. Metabotropic Glutamate Receptor 2 Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
